A Multicenter, Open Label, Dose Finding Study to Evaluate Efficacy and Safety of Givinostat Administered in Two Different Doses in Patients With Poly JIA Not Adequately Responding to the Standard Treatment.

Trial Profile

A Multicenter, Open Label, Dose Finding Study to Evaluate Efficacy and Safety of Givinostat Administered in Two Different Doses in Patients With Poly JIA Not Adequately Responding to the Standard Treatment.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Givinostat (Primary)
  • Indications Juvenile rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Italfarmaco
  • Most Recent Events

    • 21 Jun 2012 Additional location added as reported by ClinicalTrials.gov.
    • 21 Jun 2012 Additional location added as reported by ClinicalTrials.gov.
    • 21 Jun 2012 Actual patient number is 16 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top